Introduction
============

In the last years an increase of allergic diseases could be observed. Prevalence of food allergy is highest in infants (6--8%) and decreases slightly with age, affecting almost 4% of the adults (Cianferoni and Spergel, [@B5]). In most studies on allergic manifestations post-translational modifications like glycosylation of the allergenic proteins were not taken into account. The term "glycosylation" describes the covalent linkage of an oligosaccharide side chain to a protein. In most glycoproteins the oligosaccharide chain is attached to the amide nitrogen of an asparagine (Asn) residue (*N*-glycosylation) and/or to the hydroxyl group of threonine (Thr), serine (Ser), or hydroxylproline (Hyp; *O*-glycosylation) residues of the peptide backbone (Saint-Jore-Dupas et al., [@B33]). The protein *N*-glycosylation starts in the endoplasmic reticulum (ER) with co-translational transfer of an oligosaccharide precursor, Glc~3~Man~9~GlcNAc~2~, onto specific Asn residues. After the transfer onto the nascent protein and during glycoprotein transport along the secretory pathway, *N*-linked oligosaccharides undergo several maturation steps involving the removal of glucose (Glc) and Mannose (Man) residues to generate high-mannose type *N*-glycans and the addition of new sugar residues in the ER and the Golgi apparatus, to generate complex type *N*-glycans (Gomord and Faye, [@B12]; Saint-Jore-Dupas et al., [@B33]). Up to now three major types of *N*-glycans have been described in plants, the high-mannose-, the hybrid-, and the complex type (Foetisch and Vieths, [@B10]). The high-mannose type *N*-glycans contain five to nine mannose residues and no further sugar residues. In *N*-glycans of the complex type β-mannose is substituted by a bisecting β1,2-xylose and/or the proximal *N*-acetylglucosamine of the core is substituted by a α1,3-fucose.

The β1,2-xylose and the α1,3-fucose residues are not present in mammals and therefore constitute IgE-binding epitopes for carbohydrate reactive antibodies. The two main motifs, xylose and the core-3-linked fucose, form two essentially independent epitopes (Altmann, [@B1]). Plants contain both epitopes, insect glycoproteins only fucose. Their allergenicity and clinical relevance have been discussed for years (Tretter et al., [@B41]; van Ree et al., [@B44]; Bencurova et al., [@B2]). They are regarded as the major class of the so-called "carbohydrate cross-reactive determinants" (CCDs; Wilson and Altmann, [@B47]) reactive with IgE antibodies in the sera of many allergic patients (Strasser et al., [@B37]), however their clinical relevance is still under debate. Structurally similar CCDs are present in many plants and invertebrates. CCD-specific IgE antibodies may bind to several of them in unrelated species which often contributes to false-positive results *in vitro* when only CCD-specific IgEs bind to extracts and allergens (van Ree et al., [@B44]; Foetisch et al., [@B11]; Mahler et al., [@B26]; Altmann, [@B1]).

In addition, larger complex type plant *N*-glycans were identified containing additional β1,3-galactose and α1,4-fucose residues linked to the terminal *N*-acetylglucosamine units. These *N*-glycans are known as Lewis a antigens and are usually found on cell surface glycoconjugates in mammals (Fitchette-Lainé et al., [@B9]; Melo et al., [@B28]). In the meantime, Lewis a epitopes were also found in many plant extracts and constitute another possible source of cross-reactivity (Foetisch and Vieths, [@B10]).

Some studies concerning the production of therapeutic proteins in plants circumvent the problem of plant specific glycosylation by silencing the glycosyltransferases XylT and FucT, which are crucial for transferring the representative sugar residues to glycoproteins (Strasser et al., [@B37]; Cox et al., [@B6]). Strasser et al. ([@B39]) were able to modulate the *N*-glycan composition in *Nicotiana benthamiana* by simultaneous silencing of FucT and XylT. Using XylT/FucT silenced transgenic plants for transient expression of the human anti-HIV monoclonal antibody 2G12, the plant-made antibody contained an almost homogeneous *N*-glycan species without detectable β1,2-xylose and α1,3-fucose residues.

Here, we report on the successful modulation of *N*-glycosylation in transgenic tomato plants. To generate hypo-allergenic tomato fruits and to test the clinical relevance of β1,2-xylose, the gene coding for β1,2-xylosyltransferase was down-regulated by RNA interference (RNAi) in transgenic tomato plants. The allergenic potency of transgenic XylT_RNAi tomato fruits was analyzed by different molecular tests. The XylT_RNAi lines exhibited a successful inhibition of XylT expression in the transgenic tomato plants. The accumulation of the XylT transcript was 10-fold less compared to untransformed samples. On the basis of IgE immunoblotting assays XylT_RNAi tomato fruits revealed a patient-specific reduction in IgE reactivity, indicating a reduced allergenic reactivity *in vitro* caused by the XylT suppression. Furthermore, patients with tomato allergy had reduced mean wheal diameters in skin prick tests (SPT), demonstrating a reduced allergenic potential of XylT_RNAi tomato fruits *in vivo*.

Results
=======

RNAi-mediated silencing of β1,2-xylosyltransferase expression in fruits of transgenic tomato plants
---------------------------------------------------------------------------------------------------

To achieve down-regulation of XylT expression in transgenic tomato plants, a 475 bp fragment of the coding sequence of XylT was cloned in sense and antisense-orientation into the vector pK7GWIWG2(II; Karimi et al., [@B16]) in order to create the final transformation plasmid pK7GWIWG2--XylT (Figure [1](#F1){ref-type="fig"}A). The binary RNAi construct was used for *Agrobacterium tumefaciens* mediated transformation of the tomato var. MicroTom. A total of 24 kanamycin-resistant tomato plants (referred as XylT_RNAi plants) were generated. The XylT_RNAi tomato plants were subsequently analyzed on the mRNA level to validate the degree of silencing. For quantitative real-time PCR (qPCR) analysis the total RNA was extracted from tomato fruits and 4 μg of the RNA were translated into cDNA. Figure [1](#F1){ref-type="fig"}B shows the relative expression of XylT mRNA in tomato fruits from wild type (WT) and individual plants of the T1-generation of XylT_RNAi lines 3, 9, and 12. The relative expression levels of the different transgenic lines varied. Compared to the untransformed control, XylT transcript levels were reduced 83% (line 3), 76% (line 12), and 20% (line 9), respectively.

![**Silencing of XylT expression in transgenic tomato plants**. **(A)** Scheme of the XylT_RNAi construct (XylT in sense and antisense orientation). p35: 35S cauliflower mosaic virus promoter; T35S: terminator; attB1, attB2: recombination sites; CmR chloramphenicol acetyltransferase gene. **(B)** qPCR of three selected transgenic lines with reduced XylT expression. Total RNA of green fruits was extracted and 4 μg of total RNA were reversed transcribed. The resulting cDNA was used as template for qPCR analysis.](fpls-02-00042-g001){#F1}

Silencing of the β1,2-xylosyltransferase leads to a strong reduction in β1,2-xylose-containing epitopes of glycoproteins
------------------------------------------------------------------------------------------------------------------------

For the detection of β1,2-xylose-containing *N-*glycans, protein extracts from XylT_RNAi, and WT tomato fruits were subjected to immunoblot analysis. Protein extracts of fruits were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted onto nitrocellulose membranes. For immunodetection of xylose residues, a xylose-specific IgG antibody was used. In protein extracts from fruits of untransformed WT controls, binding of the anti-xylose antibodies to several proteins could be detected, indicating the presence of different proteins carrying β1,2-xylose epitopes (Figure [2](#F2){ref-type="fig"}A). Binding of the anti-xylose antibodies to proteins from fruits of XylT_RNAi plants was undetectable or strongly reduced, indicating the lack of xylose residues (Figure [2](#F2){ref-type="fig"}A). To ensure the equal amounts of protein a silver stained SDS-gel was used as loading control (Figure [2](#F2){ref-type="fig"}B).

![**Detection of xylose-containing *N-*glycans in protein extracts from transgenic XylT_RNAi and wild type tomato fruits**. **(A)** Immunoblot analysis of β1,2-xylose-containing *N*-glycans of WT (lane 1 and 6) and independent T2 plants of XylT_RNAi line 3 (lanes 2--5) and XylT_RNAi line 12 (lanes 7--10), the β1,2-xylose-containing *N*-glycans were visualized using anti-β-1,2-xylose-specific antibodies. Protein standards of 55 and 36 kDa are represented by arrow heads. **(B)** SDS-PAGE and silver staining of protein extracts from green fruits.](fpls-02-00042-g002){#F2}

To further characterize the *N*-linked oligosaccharides, protein extracts from XylT_RNAi fruits were tested by ConA-affinoblotting. ConA binds to high-mannose (alpha-d-mannosyl groups at the non-reducing terminus of oligosaccharides) but not to complex *N*-glycans and therefore allows distinguishing both *N*-glycans. As shown in Figure [3](#F3){ref-type="fig"}A, ConA binding to a number of glycoproteins can be detected in control extracts. In extracts from red fruits of two independent XylT_RNAi lines, 3 and 12, ConA binding to glycoproteins was strongly enhanced. Since the total amount of protein per lane was equal (Figure [3](#F3){ref-type="fig"}B) this observation suggests that abolishing XylT activity enhances the occurrence of high-mannose type *N*-glycans. In view of the fact that complex *N*-glycans not only carry β1,2-xylose but also α1,3-fucose residues, glycoproteins of WT and XylT_RNAi lines were analyzed for the presence of both sugar moieties using anti-xylose and anti-fucose antibodies, respectively. As shown in Figure [4](#F4){ref-type="fig"}, strong reduction in xylose-containing epitopes (Figure [4](#F4){ref-type="fig"}A) in green (Figure [4](#F4){ref-type="fig"}, lanes 1--3), orange (Figure [4](#F4){ref-type="fig"}, lanes 4--6), and red (Figure [4](#F4){ref-type="fig"}, lanes 7--9) tomato fruits is paralleled by a slight reduction of fucose-containing epitopes (Figure [4](#F4){ref-type="fig"}B). To clarify the observed changes in *N*-glycan composition the *N*-glycosylation profile of WT and XylT_RNAi lines 3 and 12 was determined by LC--ESI--MS analysis. The mass spectrum of WT plants revealed that the vast majority of the *N*-glycan species carried xylose and α1,3-fucose residues. The XylT_RNAi lines exhibited a complete loss of β1,2-xylosylated *N*-glycans. The XylT knock-down lines, only contained either core α1,3-fucosylated structures (MMF, MGnF~iso~, GnGnF) or glycans devoid of any of the two plant-typical immunogenic determinants (Figure [5](#F5){ref-type="fig"}). At this point it should be highlighted that all XylT_RNAi lines were viable and did not exhibit any obvious phenotype under standard growth conditions (data not shown).

![**Analysis of high-mannose-containing *N*-glycans with ConA affinity blotting**. **(A)** Twenty-two micrograms of total soluble protein from red fruits of *L. esculentum* cv. MicroTom wild type (WT, lane 1), XylT_RNAi line 3 (lanes 2--3), or XylT_RNAi line 12 (lanes 4--5) were loaded per lane. Fruits analysed were derived from the T1-generation of transgenic plants. Lane 2, XylT_RNAi 3--1; lane 3, XylT_RNAi 3--7; lane 4 XylT_RNAi 12--4; lane 5, XylT_RNAi 12--12. **(B)** Silver staining of protein extracts.](fpls-02-00042-g003){#F3}

![**Detection of fucose-containing *N-*glycans in protein extracts from transgenic XylT_RNAi and wild type tomato fruits**. **(A)** Immunoblot using anti-xylose IgG antibodies; **(B)** Immunoblots using anti-fucose IgG antibodies; **(C)** Silver staining of SDS-PAGE. Protein extracts from green (lanes 1--3), orange (lanes 4--6), and red (lanes 7--9) tomato fruits were separated by SDS-PAGE and probed for xylose- or fucose-containing epitopes. Lanes 1, 4, and 7, protein extracts from wild type controls; lanes 2, 5, and 8, protein extracts from the T2 generation of line XylT_RNAi 3--16--10; lanes 3, 6, and 9, protein extracts from the T2 generation of line XylT_RNAi 12--15--1. Arrow heads indicate protein standards of 95, 55, and 36 kDa, respectively.](fpls-02-00042-g004){#F4}

![***N*-glycosylation analysis of tomato proteins by mass spectrometry**. The area percentages were calculated from the peak areas within the mass spectra. Absolute SDs are typically in the range of 1--3% with larger values for larger peaks and vice versa. Glycans carrying a xylose residue (MMX, MMXF, MGnX~iso~, MGnXF~iso~, GnGnXF) were detected in the WT sample, but not in XylT-RNAi samples. These contained increased amounts of the non-immunogenic *N*-glycans such as Man3 and MGn~iso~. *N*-glycans are annotated according to ProGlycan nomenclature (<http://www.proglycan.com/>).](fpls-02-00042-g005){#F5}

Reduced allergenic potency of XylT_RNAi tomato fruits *in vitro* determined by IgE immunoblotting
-------------------------------------------------------------------------------------------------

Three symptomatic tomato allergic patients with a specific IgE-binding to a 52 kDa-protein were recruited to test their *in vivo* allergic reactivity to XylT-reduced tomato fruits. Sera of these patients were used for further *in vitro* IgE immunoblotting and CAP FEIA (UniCAP 100, Phadia, Freiburg, Germany) analysis. Table [1](#T1){ref-type="table"} shows the demographic data, allergic symptoms and the patient history as well as specific IgE levels of all investigated patients. Representative IgE-binding patterns to total soluble proteins from WT and XylT_RNAi tomato fruits are shown in Figure [6](#F6){ref-type="fig"}. For the IgE immunoblot analysis, protein extracts of WT (Figure [6](#F6){ref-type="fig"}, lane 1) and XylT_RNAi lines 3 (Figure [6](#F6){ref-type="fig"}, lane 2), 9 (Figure [6](#F6){ref-type="fig"}, lane 3), and 12 (Figure [6](#F6){ref-type="fig"}, lane 4) were separated on SDS-PAGE and subsequently blotted onto nitrocellulose membranes. The membranes were first incubated in diluted patient\'s serum, and then transferred into a diluted anti-human IgE antibody, conjugated with peroxidase. Sera from all three tomato allergic patients tested showed a strong IgE-binding to proteins from fruits of control plants (Figures [6](#F6){ref-type="fig"}A--C). This binding was abolished (Figure [6](#F6){ref-type="fig"}A) or strongly reduced (Figures [6](#F6){ref-type="fig"}B,C) in extracts from transgenic tomato fruits, indicating that β1,2-xylose epitopes are constitutive determinants for IgE-binding.

###### 

**Characterization of patients (history, allergic symptoms, specific IgE (CAP FEIA analysis)**.

  ID      Age   Gender   Diagnosis/clinical symptoms                                                                                                                   CAP tomato fruit      CAP bee venom         CAP yellow jacket venom   CAP rapeseed            CAP bromelin          CAP horseradish peroxidase
  ------- ----- -------- --------------------------------------------------------------------------------------------------------------------------------------------- --------------------- --------------------- ------------------------- ----------------------- --------------------- ----------------------------
  T 018   49    F        OAS and contact urticaria (tomato fuit), seasonal rhinoconjunctivitis (birch pollen)                                                          0.61 kU/l (class 1)   0.80 kU/l (class 2)   0.82 kU/l (class 2)       0\. 64 kU/l (class 1)   0.50 kU/l (class 1)   0.40 kU/l (class 1)
  T 029   51    F        OAS (tomato fruit and carrot, seasonal rhinoconjunctivitis (birch pollen)                                                                     11.9 kU/l (class 3)   44.2 kU/l (class 4)   3.04 kU/l (class 2)       27.2 kU/l (class 4)     6.00 kU/l (class 3)   6.25 kU/l (class 3)
  T 039   54    M        OAS, Quickes′ edema and dypnoea (tomato fruit), seasonal rhinoconjunctivitis (birch pollen)                                                   0.14 kU/l (class 0)   0.21 kU/l (class 0)   0.05 kU/l (class 1)       0\. 68 kU/l (class 1)   0.05 kU/l (class 0)   0.02 kU/l (class 0)
  V 001   22    F        Type I allergy to yellow jacket venom (grade I according to Mueller), ongoing specific immunotherapy (yellow jacket venom)                    0.58 kU/l (class 1)   0.73 kU/l (class 2)   0.97 kU/l (class 2)       0\. 80 kU/l (class 2)   0.57 kU/l (class 1)   0.67 kU/l (class 1)
  V 002   32    F        Type I allergy to yellow jacket venom (grade II according to Mueller), ongoing specific immunotherapy (yellow jacket venom)                   0.15 kU/l (class 0)   0.24 kU/l (class 0)   27.4 kU/l (class 4)       0\. 17 kU/l (class 0)   0.15 kU/l (class 0)   0.10 kU/l (class 0)
  V 003   74    M        Type I allergy to bee and yellow jacket venom (grade IV according to Mueller), ongoing specific immunotherapy (bee and yellow jacket venom)   0.01 kU/l (class 0)   0.94 kU/l (class 2)   0.20 kU/l (class 0)       0\. 00 kU/l (class 0)   0.01 kU/l (class 0)   0.00 kU/l (class 0)
  V 004   24    M        Type I allergy to bee and yellow jacket venom (grade III according to Mueller)                                                                0.33 kU/l (class 0)   26.6 kU/l (class 4)   10.1 kU/l (class 3)       0\. 52 kU/l (class 1)   0.57 kU/l (class 1)   0.71 kU/l (class 2)
  V 005   45    M        Type I allergy to yellow jacket venom (grade II according to Mueller)                                                                         0.11 kU/l (class 0)   0.18 kU/l (class 0)   1.12 kU/l (class 2)       0\. 11 kU/l (class 0)   0.10 kU/l (class 0)   0.09 kU/l (class 0)
  V 006   21    F        Type I allergy to yellow jacket venom (grade II according to Mueller), ongoing specific immunotherapy (yellow jacket venom)                   0.11 kU/l (class 0)   0.97 kU/l (class 2)   3.37 kU/l (class 2)       0.11 kU/l (class 0)     0.08 kU/l (class 0)   0.10 kU/l (class 0)
  V 008   50    M        Type I allergy to bee venom (grade II according to Mueller), ongoing specific immunotherapy (bee venom)                                       0.53 kU/l (class 1)   6.39 kU/l (class 3)   1.28 kU/l (class 2)       0\. 53 kU/l (class 1)   0.47 kU/l (class 1)   0.5 kU/l (class 1)
  V 010   61    M        Type I allergy to yellow jacket venom (grade II according to Mueller), ongoing specific immunotherapy (yellow jacket venom)                   5.01 kU/l (class 3)   4.30 kU/l (class 3)   29.5 kU/l (class 4)       5\. 37 kU/l (class 3)   4.00 kU/l (class 3)   5.01 kU/l (class 3)
  V 011   78    F        Type I allergy to bee and yellow jacket venom (grade 0 according to Mueller)                                                                  1.67 kU/l (class 2)   1.80 kU/l (class 2)   5.45 kU/l (class 3)       2\. 05 kU/l (class 2)   1.75 kU/l (class 2)   2.06 kU/l (class 2)
  V 012   45    M        Type I allergy to bee venom (grade III according to Mueller), ongoing specific immunotherapy (bee venom)                                      0.01 kU/l (class 0)   1.33 kU/l (class 2)   0.30 kU/l (class 0)       0\. 01 kU/l (class 0)   0.02 kU/l (class 0)   0.00 kU/l (class 0)
  V 013   20    M        Type I allergy to bee venom (grade II according to Mueller), ongoing specific immunotherapy (bee venom)                                       2.59 kU/l (class 2)   10.6 kU/l (class 3)   0.07 kU/l (class 0)       1\. 23 kU/l (class 2)   0.22 kU/l (class 0)   0.31 kU/l (class 0)
  V 014   49    M        Type I allergy to bee venom (grade 0 according to Mueller)                                                                                    0.02 kU/l (class 0)   10.3 kU/l (class 3)   0.03 kU/l (class 0)       0\. 02 kU/l (class 0)   0.02 kU/l (class 0)   0.01 kU/l (class 0)

*Demographic data \[age, gender (male/female)\], medical history, and symptoms of tomato allergic (T) or insect venom allergic (V) individuals after contact with tomato or hymenoptera venoms, respectively, are displayed. Severity of allergic insect sting reactions is classified as grade 0--IV according to Mueller ([@B30]). Specific IgE and CAP classes levels were measured by UniCAP 100. Specific IgE in insect venom allergic individuals under specific immunotherapy to some extent have changed compared to the time, when the diagnostic work-up had been done \[e.g., in individual V 003 at the start of the treatment specific IgE to yellow jacket venom had been 1.04 kU/l (CAP class 2)\]*.

![**IgE-binding and allergenic potency of XylT_RNAi tomato fruits**. Investigation of IgE-binding to soluble protein extracts from red fruits of *L. esculentum* cv. MicroTom wild type (WT, lane 1), XylT_RNAi line 3 (lane 2), XylT_RNAi 12 (lane 3), and XylT_RNAi 6 (lane 4). Proteins were separated on 12.5% SDS-PAGE, blotted to nylon membranes and probed with sera from tomato allergic patient T 039 **(A)**, T 018 **(B)**, and T 029 **(C)**. Arrow heads indicate protein standards of 55 and 36 kDa, respectively.](fpls-02-00042-g006){#F6}

Since complex *N*-glycans carrying α1,3-fucose, but lacking β1,2-xylose, are naturally found in some invertebrate glycoproteins such as hymenoptera venoms (Wilson and Altmann, [@B47]; Altmann, [@B1]), we decided to investigate the IgE-binding pattern of XylT_RNAi tomato lines with serum IgE antibodies obtained from hymenoptera allergic patients. Fruit extracts from WT and XylT_RNAi lines were subjected to IgE immunoblot analysis using two representative sera from bee and yellow jacket venom allergic patients (Table [1](#T1){ref-type="table"}; V 008, V 011). Serum from the bee/yellow jacket venom allergic patient V 008 showed a strong binding to WT tomato fruits (Figure [7](#F7){ref-type="fig"}A, lane 1) and the XylT_RNAi extracts (Figure [7](#F7){ref-type="fig"}A, lane 2, XylT_RNAi 3--16; lane 3, XylT_RNAi 12--4). IgE antibodies of the bee/yellow jacket venom allergic patient V 011 demonstrated in the IgE immunoblotting analysis clear reaction toward WT tomato extracts (Figure [7](#F7){ref-type="fig"}B, lane 1), whereas the IgE-binding to proteins of transgenic XylT_RNAi line 3--16 (Figure [7](#F7){ref-type="fig"}B, lane 2) and XylT_RNAi line 12--4 (Figure [7](#F7){ref-type="fig"}B, lane 3) was slightly reduced.

![**Immunoblot analysis of hymenoptera allergic patients**. Immunoblots of tomato red fruits extracts were incubated with selected sera from hymenoptera allergic patients (see Table [1](#T1){ref-type="table"}) V 008 **(A)** and V 011 **(B)** and developed for detection of human IgE. **(C)** Protein staining with silver as loading control. Lane 1, WT; lane 2, XylT_RNAi 3--16; lane 3, XylT_RNAi 12--4. Blotted WT extracts showed reduced IgE-binding after PNGase A treatment. **(D)** V 008, **(E)** V 011, **(F)** Silver staining of proteins as loading control. Arrow heads show protein standards of 55 and 36 kDa.](fpls-02-00042-g007){#F7}

To release the carbohydrate moieties, protein extracts from WT fruits were treated with peptide-*N*-glycosidase (PNGase) A, which is able to remove the complex fucose-containing glycans of plant glycoproteins, in contrast to PNGase F (Tretter et al., [@B42]). After incubation with PNGase A for 36 h, the serum of patient V 008 exhibited a decrease in IgE-binding to deglycosylated protein extracts, compared with control extract (Figure [7](#F7){ref-type="fig"}D). The additional band at about 62 kDa represents most likely the PNGase A itself (Figure [7](#F7){ref-type="fig"}D, lane 2). When using the serum of bee/yellow jacket venom allergic patient V 011, most of the glycoprotein previously detected had lost its IgE-binding capacity after deglycosylation (Figure [7](#F7){ref-type="fig"}E).

Taken together, the IgE-binding to the 55 kDa-allergen in tomato is due to a xylose-containing epitope recognized by selective tomato allergic individuals, independently from a fucose-containing epitope also recognized by venom allergic individuals.

Reduced allergenic potency of XylT_RNAi tomato fruits *in vivo* determined by skin prick test
---------------------------------------------------------------------------------------------

Fruits from XylT_RNAi lines and untransformed controls were used for a prick-to-prick test in three selected tomato allergic patients with known IgE-binding to the 52 kDa-component. The wheal-and-flare reactions elicited by XylT_RNAi transgenic tomato fruits differed in the individual patients dependent on their co-sensitization to additional tomato proteins (Table [2](#T2){ref-type="table"}). In mono-sensitized patient T 039 with exclusive IgE-binding to the 52 kDa-allergen of the tomato, depending on the cultivar (Cv) a reduction of the mean wheal diameter of 4.3 (line XylT_RNAi 12--12) to 82.6% (lines XylT_RNAi 3--16 and line XylT_RNAi 12--3) was found in SPT with XylT_RNAi tomato fruits compared to the untransformed WT control (Table [2](#T2){ref-type="table"}; patient T 039). A reduction of the mean wheal diameter was also observed in two other patients sensitized to the 52 kDa-allergen in SPT with the XylT-reduced tomato fruits, despite these patients were not mono-sensitized and the reduction of the IgE-mediated reactivity in the SPT was influenced by IgE-binding to non-silenced further allergens. In patient T 029 a reduction of 0 (line XylT_RNAi 12--3) to 100% (line XylT 3--1) could be noticed (Table [2](#T2){ref-type="table"}, patient T 029). Patient T 018 exhibited a reduction of mean wheal diameter of 18.2 (line XylT_RNAi 3--1) to 100% (line XylT_RNAi 3--16; Table [2](#T2){ref-type="table"}, patient T 018).

###### 

**Skin prick tests with XylT-silenced tomato fruits**.

  Probe              Patient T 039   Patient T 018   Patient T 029
  ------------------ --------------- --------------- ---------------
                     MWD (mm)        MWD (mm)        MWD (mm)
  Histamine          5.25            6               6.5
  Sodium chloride    0               0               0
  XylT_RNAi 3--1     3               3.6             0
  XylT_RNAi 3--7     2               2.75            8
  XylT_RNAi 3--10    4.5             3               5.5
  XylT_RNAi 3--16    1               0               4.5
  XylT_RNAi 12--3    1               2.5             9.85
  XylT_RNAi 12--4    2               5               6
  XylT_RNAi 12--12   5.5             3.25            8
  XylT_RNAi 12--15   5               3.5             4.5
  Wild type          5.75            4.4             8.75

*Skin-prick-test of tomato allergic patients using fruits of WT, XylT-silenced (XylT_RNAi) lines 3, and 12. The mean wheal diameters (MWD) are indicated in millimeters. Histamine dihydrochloride was used as positive control*.

Sera from Lyc e 2-sensitized patients show a strongly reduced IgE-binding to proteins from XylT_RNAi tomato fruits
------------------------------------------------------------------------------------------------------------------

Examination of the immunoblots revealed one major immuno-reactive protein migrating at a molecular weight of approximately 52 kDa, reminiscent of Lyc e 2, a major allergen of tomato fruits. Lyc e 2 is a glycoprotein with β-fructofuranosidase (E. C. 3.2.1.26) or soluble acid invertase activity. To test, whether the β1,2-xylose residues would be required for IgE-binding, sera of two Lyc e 2-sensitized patients (Westphal et al., [@B46]) were used for IgE immunoblot analysis. In control extracts IgE-binding to high-molecular-weight bands could be found for both Lyc e 2-sensitized patients. In contrast, no IgE-binding could be detected with the protein extracts from XylT_RNAi tomato fruits (Figures [8](#F8){ref-type="fig"}A,B). The loading control is shown in Figure [8](#F8){ref-type="fig"}C.

![**Immunoblot of XylT_RNAi tomato fruits using IgE from Lyc e 2-sensitized patients**. IgE-binding to soluble protein extracts from red tomato fruits harvested from *L. esculentum* cv. MicroTom wild type (WT, lanes 1 and 6), XylT_RNAi line 3 (lanes 2--5), XylT_RNAi 12 (lanes 7--10). **(A)** IgE-binding using serum from patient 7241--7, **(B)** IgE-binding using serum from patient 8695--24. Fruits analyzed were derived from the T1-generation of transgenic plants. Lane 2, XylT_RNAi 3--1; lane 3, XylT_RNAi 3--7; lane 4, XylT_RNAi 3--10; lane 5, XylT_RNAi 3--16; lane 7, WT; lane 8, XylT_RNAi 12--3; lane 9, XylT_RNAi 12--4; lane 10, XylT_RNAi 12--12. **(C)** SDS-PAGE and silver staining of protein extracts from red fruits. Arrow heads indicate protein standards of 95, 55, and 36 kDa, respectively.](fpls-02-00042-g008){#F8}

These results suggest that β1,2-xylose is a major determinant of the Lyc e 2 IgE-specific epitope.

Soluble acid invertase activity is unaltered in transgenic XylT_RNAi plants
---------------------------------------------------------------------------

To rule out that the reduced binding to Lyc e 2 in extracts from XylT_RNAi lines was due to a reduced accumulation of soluble acid invertase, enzyme activity was measured in leaves and fruits of transgenic and control tomato plants. As shown in Figure [9](#F9){ref-type="fig"}, soluble acid invertase activity in protein extracts from transgenic plants was indistinguishable from the activity determined in control extracts. Thus down-regulation of the XylT does not negatively influence the accumulation and activity of Lyc e 2, as determined by invertase measurement.

![**Invertase enzyme activity measurements**. Soluble invertase activity in protein extracts from leaves of *L. esculentum* cv. MicroTom wild type (WT) and independent T1-plants of transgenic XylT_RNAi line 3 and 12.](fpls-02-00042-g009){#F9}

Discussion
==========

Reduction of food allergens by means of RNA interference
--------------------------------------------------------

Food allergies represent an increasing health concern impairing quality of life in affected adults and children. As until now no specific immunotherapy for food allergies is available, avoidance of the respective food is the current primary treatment option. Up to now different breeding activities have been undertaken to select for low-allergenic Cvs (Bolhaar et al., [@B3]; Zuidmeer et al., [@B49]). However, so far no commercial variety has been obtained. The difficulties in breeding for low-allergenic varieties may in part be due to environmental factors regulating allergen accumulation during growth and storage which renders classical selection procedures difficult (Scheurer and Sonnewald, [@B34]). Some approaches for the suppression of known allergens in food by means of genetic engineering have been followed in the last years for soybean, rice, peanut, cherry, apple, and tomato (reviewed in Scheurer and Sonnewald, [@B34]). Most of these approaches used the so-called RNAi to reduce expression of allergenic proteins. RNAi has been shown to be a selective and robust tool, but it may also have limitations. Some biotic and abiotic factors were found effecting the stability and efficacy of RNAi under varying environmental conditions (Szittya et al., [@B40]). Many plant viruses encode suppressors of silencing (Roth et al., [@B32]) which could counteract the application of the RNAi technology under field conditions. This could potentially be overcome by applying artificial microRNAs to suppress expression of allergenic proteins. Another limitation of gene silencing resides in the observation that several allergens represent essential cellular functions (Le et al., [@B20]). To overcome this problem simultaneous over-expression of hypo-allergenic variants of the respective allergen would be required. In a recent study, Le et al. ([@B21]) could demonstrate that the growth penalty of Lyc e 1 silencing could be overcome by co-expression of yeast profilin. One further limitation in designing hypo-allergenic food is that most allergic patients are not only sensitized to one single allergen, but to multiple proteins from the respective food. Therefore, multi-target silencing will be the next challenge for future experiments.

Modulation of *N*-glycosylation in plants
-----------------------------------------

In all eukaryotic cells glycosylation of asparagine residues (*N*-glycosylation) is a highly conserved co-translational modification of secreted proteins. The process is separated into core-glycosylation and glycan maturation. The core-glycosylation takes place in the ER where pre-assembled core oligosaccharides (Glc~3~Man~9~GlcNac~2~) are transferred to asparagine residues of the Asn/X-Ser/Thr motives in nascent polypeptides. The glycan maturation in the Golgi apparatus has been shown to be crucial for the formation of complex *N*-glycans. In the last years several plant mutants lacking complex *N*-glycans were published. The first one was the *cgl1* mutant in 1993 (von Schaewen et al., [@B45]). In the meantime, several mutants and transgenic plants which were devoid of potentially immunogenic complex *N*-glycans have been generated and are used for the production of pharmaceutical proteins in the respective plants (Lerouge et al., [@B23]; Koprivova et al., [@B19]; Cox et al., [@B6]; Strasser et al., [@B39], [@B38]). The plant specific sugar residues, β1,2-xylose and α1,3-fucose are not present in mammals and therefore constitute epitopes for carbohydrate reactive antibodies (Tretter et al., [@B41]; Wilson and Altmann, [@B47]; van Ree et al., [@B44]; Bencurova et al., [@B2]). An overall prevalence of specific anti-glycan IgE of 23% in human sera has been described with an increase up to 71% (in individuals with multiple pollen sensitivity) according to the examined subset. These CCD dependent IgE antibodies are often accompanied by IgG, but the clinical relevance is still under debate. A clinical insignificance of CCDs has been proposed in some studies (van der Veen et al., [@B43]; Mari, [@B27]). In a recent study Kaulfürst-Soboll et al. ([@B17]) used transgenic tomato plants with an overall reduction in protein *N*-glycosylation and confirmed the low clinical significance of CCDs.

In our study we addressed the question whether down-regulation of β1,2-xylose-containing epitopes would reduce the allergenic potential of tomato fruits in respective tomato allergic individuals sensitized to a 52 kDa-allergen.

To this end RNAi was used to down-regulate the expression of XylT in tomato plants. Immunoblot analysis revealed that accumulation of glycoproteins carrying β1,2-xylose were strongly reduced in transgenic XylT_RNAi lines in comparison to control extracts (Figure [2](#F2){ref-type="fig"}A). Reduced accumulation of XylT mRNA was confirmed for XylT_RNAi lines 3, 12, and 9 by qPCR (Figure [1](#F1){ref-type="fig"}B). Strongly reduced xylose content of *N-*glycans resulted in enhanced ConA binding and a slight reduction in fucose content of glycoproteins from XylT_RNAi plants, as determined by immunoblotting (Figures [3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}B). The changes in *N*-glycosylation pattern in XylT_RNAi lines were monitored in *N*-glycan analysis by MS. The *N*-glycan profile of the WT sample demonstrated that the vast majority of the *N*-glycan species were xylosylated and fucosylated. In contrast to the WT *N*-glycosylation pattern, the mass spectrum of the XylT_RNAi plants revealed a complete loss of β1,2-xylose and a reduction of fucose carrying *N*-glycans (Figure [5](#F5){ref-type="fig"}). This finding is in agreement with results obtained by analyzing XylT knockout lines in Arabidopsis, which showed an increase in high-mannose and a decrease in fucose-containing *N*-glycans (Strasser et al., [@B37]). Using sera of tomato allergic patients, a decreased residual IgE-binding to proteins from XylT_RNAi plants could be detected for two patients, whereas one patient revealed no IgE reactivity toward the XylT_RNAi tomato lines 3 and 12 (Figure [6](#F6){ref-type="fig"}). In contrast, IgE-binding of sera from insect allergic patients evidently raised against a fucose-containing epitope was maintained in xylose reduced XylT_RNAi tomato lines (Figure [7](#F7){ref-type="fig"}).

When patients T 029 and T 018 were challenged in SPT depending on the Cv and their co-sensitizations to additional tomato allergens they showed only a scarce reduction of the skin reaction to XylT_RNAi fruits (Table [1](#T1){ref-type="table"}, patient T 029 and T 018). Patient T 039 with a clear history of clinically relevant tomato allergy was shown to be mono-sensitized to the 52 kDa tomato protein, which we could identify as Lyc e 2. In the SPT a visible reduction in mean wheal diameters with five out of eight XylT_RNAi Cvs could be observed.

Lyc e 2 has been identified as one of the major allergens in tomato fruits. Kondo et al. ([@B18]) have reported that sera of most patients with an oral allergy syndrome to tomato positively responded to Lyc e 2 (9 of 11 patients). In our collective of tomato allergic patients, only 4.4% of patients (3 of 68) were sensitized against this allergen (only one of them monosensitized to this allergen).

Lyc e 2 is known to be a vacuolar enzyme with soluble acid invertase (β-fructofuranosidase) activity (Leigh et al., [@B22]). The enzyme catalyzes the hydrolysis of sucrose into glucose and fructose. The role of soluble acid invertase in plants is complex and may change in response to developmental and environmental signals. Soluble acid invertases are considered to be important in growth, providing tissues with hexoses as a source of energy, and carbon (Scholes et al., [@B35]). To see if the silencing of the XylT and the resulting modification of the *N*-glycosylation had a negative effect on the activity of soluble acid invertase, we measured invertase activity in WT and transgenic XylT_RNAi fruits (Figure [9](#F9){ref-type="fig"}). Neither had the silencing an effect on the expression of the soluble acid invertase, nor could an effect on the activity of the enzyme be observed when comparing WT and XylT_RNAi protein extracts.

Concerning growth and development, the transgenic XylT_RNAi lines exhibited no obvious phenotypic changes compared to WT controls under ambient growth conditions. This is in accordance with results obtained for other plants in which XylT and/or FucT were silenced, like *Arabidopsis thaliana* and *Nicotiana benthamiana* (Strasser et al., [@B37], [@B39]). Nevertheless, we cannot exclude that down-regulation of XylT renders transgenic plants more susceptible to biotic and/or abiotic stress. It has been published that mutants defective in complex *N*-glycans showed enhanced salt sensitivity (Kang et al., [@B15]) and that *N*-glycosylation is required for pattern recognition to mediate plant immunity (Häweker et al., [@B14]). First experiments using the fungal pathogen *Botrytis cinerea* and different *Pseudomonas syringae* strains lead to the assumption that the plant immunity is not affected in this case (Figure [10](#F10){ref-type="fig"}), but further experiments with different biotic and abiotic stress factors are required.

![**Fungal and bacterial growth *in planta***. **(A)** Wild type tomato (MicroTom), XylT_RNAi 12--4 as well as transformed control plants were grown for 6 weeks. After this time period detached 5th and 6th leaves were placed on 0.5% water agar and drop-inoculated (4 × 20 μl drops per leaf) with conidia of *Botrytis cinerea* 522. The inoculation solution contained 5 × 10^4^ conidia/ml of 1/2 potato dextrose broth. After inoculation, lesion size was measured 4 and 7 days after inoculation. **(B)** Bacterial growth *in planta* after infection of MicroTom tomato leaves with *Pseudomonas* DC3000 and *Pseudomonas* DC3000 Δ*hrcC* Strain TLR1 **(C)** was monitored over a 13-day period. Bacteria were infiltrated with 1 × 10^5^ cfu/ml, and their growth was determined 3 and 7 days after inoculation. Values represent means of two samples taken from three infected leaves of three different plants. Error bars indicate SD. The experiment was repeated twice with similar results.](fpls-02-00042-g010){#F10}

Conclusion
==========

In our study we could demonstrate that a xylose-containing epitope is the clinically relevant epitope for Lyc e 2-sensitized tomato allergic individuals. Furthermore, we could show that β1,2-xylose modifications of *N*-glycans modify specific IgE-binding *in vitro* and *in vivo* in individuals allergic to Lyc e 2. Thus our study challenges two widely hold hypotheses. First, that human IgE reacts essentially only to the core α1,3-fucose epitope (Bencurova et al., [@B2]). Second, that IgE against carbohydrate has no clinical relevance and does not result in strong skin test reactions (Mari, [@B27]; Mertens et al., [@B29]). Possibly, Lyc e 2 is the special case of an allergen where the sugar moiety together with the protein constitutes a clinically relevant epitope.

Materials and Methods
=====================

Characterization of patients' sera
----------------------------------

Approval of the local ethics committee (faculty of medicine, University of Erlangen-Nuremberg, No. 3344) to this study and written informed consent of all participants was obtained.

For this study, three sera with specific IgE-binding to a 52 kDa-protein were used \[i.e., 4.4% out of *n* = 68 sera from tomato allergic patients (T) with clinical symptoms upon ingestion of tomato fruits (see Table [1](#T1){ref-type="table"})\]. Allergy diagnosis was based on a positive case history, positive specific IgE against tomato fruit *in vitro* and positive skin prick test results (consisting of a mean wheal diameter of more than 3 mm). For control purposes concerning specific IgE-binding to cross-reactive carbohydrate determinants, 10 sera were obtained from symptomatic insect venom allergic patients (V; Table [1](#T1){ref-type="table"}) without clinically manifest allergic reactions to tomato fruits despite elevated serum IgE to tomato extract in some of them.

Plant material and growth conditions
------------------------------------

Tomato plants (*L. esculentum* cv. MicroTom) were grown in a Percival growth chamber (Percival Scientific, Boone, USA) under a 16 h light/8 h dark cycle on Murashige--Skoog medium containing 2% (w/v) sucrose. After the initial characterization of *in vitro*-grown plants, tomato plants were transferred to a greenhouse. The plants were cultivated in soil with 16 h light followed by 8 h of darkness. The temperature regime followed the day/night cycle with 25/20°C.

Plasmid construction
--------------------

To obtain the XylT-RNAi construct the Gateway technology (Invitrogen, Karlsruhe, Germany) was used. A β1,2-xylosyltransferase (Accession Number BG130152) fragment of 475 bp was amplified from *L. esculentum* green fruit cDNA using the forward primer XylT_RNAi 5′ (5′-AATGTCCTCTTTGTTAGACG-3′) and reverse primer XylT_RNAi 3′ (5′-GTGGGTCTTGTAGAGAAAAG-3′) which were designed on the basis of sequence homology to already annotated XylT sequences in the database. PCR conditions were as follows: 95°C for 5 min *N*-acetyl-beta-glucosaminyl followed by 30 cycles of 95°C for 30 s, 55°C for 60 s, and 72°C for 60 s, and a final extension at 72°C for 10 min. The PCR fragment was introduced into pENTR/D-TOPO vector (Invitrogen) to create an entry clone containing the attL recombination sites. Subsequently, the lambda reconstruction (LR) recombination reaction was performed, according to the instructions of the manual, to transfer the fragment into the destination vector pK7GWIWG2 (II; Karimi et al., [@B16]) containing the attR attachment sites. Thereby the final construct, designated as pK7GWIWG2--XylT was generated, carrying the XylT fragment in sense and antisense orientation separated by an intron under control of the constitutive cauliflower mosaic virus 35S-promotor.

Plant transformation
--------------------

The pK7GWIWG2--XylT construct was transformed into *A. tumefaciens* CV58C1, carrying the hyper virulence attenuated tumor-inducing helper plasmid pGV2260. Tomato cotyledon explants were transformed and regenerated as described by Ling et al. ([@B24]).

### In planta growth of Botrytis cinerea and Pseudomonas syringae pv. tomato

For fungal infection WT tomato (MicroTom), XylT_RNAi 12--4 as well as transformed control plants were grown in soil at 22/18°C day/night cycle (16 h light; 53 mmol/m/s photon flux density) at 60% rel. humidity in a growth chamber. After 6 weeks detached fifth and sixth leaves were placed on 0.5% water agar (Roth) and drop-inoculated (4 × 20 μl drops per leaf) with conidia of *Botrytis cinerea* 522 (culture collection of the Institute of Phytopathology and Applied Zoology, Giessen, Germany). The inoculation solution contained 5 × 10^4^ conidia/ml of 1/2 potato dextrose broth (Duchefa). After inoculation, plates were kept at RT. Lesion size was measured 4 and 7 days after inoculation. To monitor the growth of *Pseudomonas syringae* pv. *tomato* DC3000 and *Pseudomonas* *syringae* pv. *tomato* DC3000 Δ*hrcC* Strain TLR1in tomato plants, leaves were inoculated with a bacterial suspension of 1 × 10^5^ cfu/ml. Bacterial levels *in planta* were determined by homogenizing leaf disks in sterile water, plating appropriate dilutions on NYG agar plates containing rifampicin (100 μg/ml), and counting the number of bacterial colonies.

RNA isolation and qPCR based quantification of XylT expression in transgenic plants
-----------------------------------------------------------------------------------

The quantification of XylT expression in different transgenic tomato plants was evaluated in the T1-generation of XylT-silenced plants based on Lyc e 1 transcript accumulation using RT-PCR. To this end, total RNA was isolated from leaves of 10-weeks old tomato plants as described by Logemann et al. ([@B25]). Aliquots of 4 μg total RNA were used for cDNA synthesis with the RevertAid™ First Strand cDNA Synthesis Kit from Fermentas (St. Leon-Rot, Germany). The qPCR analysis of XylT was carried out using an Mx3000P™ (Agilent Technologies, Waldbronn, Germany) and SYBR Green (Agilent Technologies) labeling following the standard protocol. A 136 bp cDNA fragment of XylT (Accession Number BG130152) was amplified using the primer XylT_RNAi qPCR f (5′-TTGGAGCCTGAAAATCTTGTAAA-3′) and XylT_RNAi qPCR r (5′-CATAAC-TGAGAGGGGCTAATA-3′). As an internal standard a 93 bp fragment of the constitutively expressed actin (NCBI-AB199316) was amplified with the primer Actin qPCR f (5′-TAATCCCAAGGCCAACAG-3′) and Actin qPCR r (5′-GAAAGCACAGCCTGGTA-3′).

Preparation of tomato protein extracts and immunoblotting
---------------------------------------------------------

For Western blotting, fruit samples (approximately 100 mg fresh weight) were homogenized in extraction buffer containing 50 mM Tris--HCl (pH 6.8), 5 mM MgCl~2~, 1 mM EDTA, 1 mM ethylene glycol-*bis*-(β-aminoethyl ether)-*N*,*N*,*N*′,*N*′-tetra acetic acid, 5 mM DTT, 0.1 mM Pefabloc proteinase inhibitor (Roche, Mannheim, Germany), and 15% glycerol. Samples were cleared by centrifugation (16.200 *g*, 15 min at 4°C) and protein content of the supernatant was determined according to the method of Bradford ([@B4]) with the BioRad protein assay solution (BioRad Laboratories, Hercules, CA, USA). An aliquot of the supernatant was immediately mixed with SDS-PAGE loading buffer, denatured at 95°C for 10 min and subjected to a 12.5% SDS-PAGE under reducing conditions. Separated proteins were blotted onto porablot NCL Nitrocellulose membrane (Macherey-Nagel, Düren, Germany). The blot was blocked in 5% (w/v) non-fat dry milk in Tris-buffered saline (TBS, 20 mM Tris--HCl, pH 7.6, 200 mM NaCl, 0.1% (v/v) Tween 20) for 1 h and afterward incubated in a 1:20000 dilution of the rabbit anti-xylose antibody (Agrisera, Vännäs, Sweden) or the rabbit anti-fucose antibody (Agrisera, Vännäs, Sweden) in TBS supplemented with 0.1% (v/v) Tween 20. Horseradish peroxidase (HRP) conjugated anti-rabbit antibody (Sigma-Aldrich, Seelze, Germany) was used as secondary antibody at 1:20000 dilution in TBS--Tween. Peroxidase detection was carried out with enhanced chemiluminescence (ECL) solution I and II.

For IgE immunoblotting the protein extracts and the SDS-PAGE were performed as described for the Western blotting. After blocking in 5% non-fat dry milk, 0.05% Tween 20, TBS pH 7.4 for 2 h, the membrane was incubated with 1:10 diluted patients' sera overnight. Immunostaining of bound IgE antibodies was performed with a HRP-conjugated goat-anti-human IgE antibody (Sigma-Aldrich) in a 1:20.000 dilution. Visualization was carried out using ECL chemiluminescence.

Deglycosylation with PNGaseA
----------------------------

For peptide-*N*-glycosidase A (PNGaseA) treatment, tomato tissue was extracted with 100 mM HEPES--KOH pH 8, supplemented with 500 mM NaCl, 2 mM Pefabloc (Serva, Heidelberg, Germany), and 1% β-mercaptoethanol. Four microgram total proteins were freeze dried and afterward boiled for 5 min in the presence of 0.1% (v/v) SDS. After addition of 10 mM sodium citrate buffer pH 5.1, 0.5 M NaSCN, 0.1 M β-mercaptoethanol, and 1 mU PNGase A (Roche, Mannheim, Germany) the samples were incubated at 37°C for 36 h. Samples were separated by SDS-PAGE, blotted on nitrocellulose and subjected to immunoblotting analysis.

Measurement of the vacuolar invertase (β-fructofuranosidase) activity
---------------------------------------------------------------------

Samples of leaf material were homogenized in liquid nitrogen with extraction buffer. The extracts were centrifuged for 5 min at 11.000 *g* at 4°C. An aliquot of the resulting supernatant was desalted by centrifugation through Sephadex G-25 medium equilibrated in extraction buffer. The desalted extracts were used for activity measurement of vacuolar invertase as described by Zrenner et al. ([@B48]). Protein concentrations were determined according to Bradford ([@B4]). Vacuolar invertase activity was determined by incubating the extracts at 37°C for 90 min. The mixture was neutralized by adding an aliquot of 1 M Tris--HCL, pH 8.0, and subsequently, the reaction was stopped by heat inactivation at 95°C for 5 min. The amount of formed glucose was measured as described by Hajirezaei et al. ([@B13]).

Analysis of *N*-glycans by liquid chromatography-mass spectrometry
------------------------------------------------------------------

Porous graphitic carbon was used as the stationary phase for separation of the borohydride-reduced glycans as described recently (Pabst et al., [@B31]; Stadlmann et al., [@B36]). Detection was performed by electrospray-ionization mass spectrometry on a Q-TOF Ultima Global instrument (Waters). Peak quantification was done with the data-mining software MassMap (MassMap GmbH & Co. KG, Wolfratshausen, Germany). Relative retention times were used to assure the identity of glycan peaks.

Affinoblotting
--------------

Glycoproteins which bind concanavalin A (ConA) can be visualized on nitrocellulose after electrophoretic transfer as described above. According to the modified protocol of Faye and Chrispeels ([@B8]) the nitrocellulose sheet was sequentially incubated with Con A and horseradish peroxidase, and the glycoproteins were visualized by staining the peroxidase with diaminobenzidine tetrahydrochloride. The nitrocellulose membrane was incubated without previous fixation steps for 1 h at room temperature in blocking solution (3% gelatine in TBS), and to visualize all proteins the blot was incubated at room temperature with gentle agitation in a buffer, referred to as TBS/gelatine cations, containing TBS, 1% gelatine, and 1 mM each of MnCl~2~ and CaCl~2~, with 25 μg/ml Con A (Roth, Karlsruhe, Germany). After 1 h the sheet was rinsed twice with TBS and washed three times for 10 min each with TBS containing 0.1% Tween 20 (TBS/T) supplemented with 1 mM MnCl~2~ and CaCl~2~. This step was followed by incubation in TBS/gelatine/cations containing horseradish peroxidase (Sigma) at a final concentration of 50 μg/ml. After 1 h the membrane was rinsed twice with TBS and washed three times for 10 min each with TBS/T with cations, briefly rinsed in TBS, and immersed in the staining solution (6 mg diaminobenzidine tetrahydrochloride, 3 mg CoCl~2~ in 10 mM Tris, pH 7.6, and 10 μl H~2~O~2~ which was freshly prepared immediately before use. Glycoproteins became visible as brown bands within 2 min of incubation. The reaction was stopped with H~2~O. Stained membranes were blotted dry, and stored in darkness.

Skin prick test
---------------

All investigations were performed in accordance with the ethical principles for medical research involving human subjects documented in the World Medical Association Declaration of Helsinki after ethical approval had been obtained from the local ethics committee (Medical Faculty, Friedrich-Alexander University Erlangen). After written consent of the patients SPT according to Dreborg ([@B7]) were performed. Red tomato fruits from MicroTom WT and different Cvs of XylT-reduced fruits were used for prick-to-prick tests in patients. Control prick test solutions (histamine 0.1 and 0.9% sodium chloride) were purchased from Allergopharma (Reinbek, Germany). Mean wheal diameters were measured after 20 min.
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